Results 71 to 80 of about 928,675 (261)

Validation of a machine learning approach to estimate Clinical Disease Activity Index Scores for rheumatoid arthritis. [PDF]

RMD Open, 2021
Spencer AK, Bandaria J, Leavy MB, Gliklich B, Su Z, Curhan G, Boussios C.   +6 more
europepmc   +1 more source

Clinical disease activity index versus disease activity score (28 joints) for assessment of disease activity in obese patients of rheumatoid arthritis

International Journal of Advances in Medicine
Background: Measurement of disease activity by Disease Activity Score 28 joints -Erythrocyte Sedimentation Rate (DAS28-ESR), Disease Activity Score (28 joints)-C-Reactive Protein (DAS28-CRP), and Clinical Disease Activity Index (CDAI) has become an integral part of management of Rheumatoid Arthritis (RA), by ‘Treatment to Target’ approach.
Sarthak Saxena, B. K. Kundu
openaire   +1 more source

The human gut microbiome across the life course

FEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero, Basak Bahcivanci, Antonietta Hayhoe, Animesh Acharjee, Ezgi Özkurt   +4 more
wiley   +1 more source

Can the Systemic Immune Inflammation Index (SII) Indicate Disease Activity in Patients with Rheumatoid Arthritis?

Türk Osteoporoz Dergisi
Objective: This study aimed to investigate the clinical utility of the systemic immune-inflammation index (SII) as a potential marker for disease activity in patients with rheumatoid arthritis (RA). Materials and Methods: A total of 104 RA patients aged
Salim Mısırcı, Alev Alp, Büşra Başar Yılmaz   +2 more
doaj   +1 more source

Validity of clinical disease activity index (CDAI) to evaluate the disease activity of rheumatoid arthritis patients in Sri Lanka: A prospective follow up study based on newly diagnosed patients. [PDF]

PLoS One, 2022
Dissanayake K, Jayasinghe C, Wanigasekara P, Dissanayake J, Sominanda A.   +4 more
europepmc   +1 more source

[Inflammatory bowel disease activity index: clinical and laboratory indicators].

Arquivos de gastroenterologia, 1996
The quantification of the degree of activity of inflammatory bowel disease is assuming growing importance nowadays. The activity index of the disease can be attained by clinical and laboratorial indicators. For ulcerative colitis the mostly used clinical parameters are daily bowel movements and presence of bloody diarrhea whereas albumin, hemoglobin ...
I, Dichi, R C, Burini
openaire   +1 more source

Degradation mechanism of the von Willebrand factor A2 domain by nattokinase

FEBS Letters, EarlyView.
Nattokinase, a natto‐derived protease, exhibits potent antithrombotic effects. This study demonstrates that nattokinase directly cleaves the von Willebrand factor (vWF) A2 domain in vitro. Unlike the native regulator ADAMTS13, nattokinase degrades folded vWF independently of shear stress.
Ryuichi Hyakumoto, Masatomo So, Ayako Furukawa, Kenji Sugase   +3 more
wiley   +1 more source

Comparison of Remission Criteria in Patients with Rheumatoid Arthritis: Results from a Smart System of Disease Management Group

Journal of Inflammation Research
Yuqi Zhang,1,2 Keqian Du,1,2 Xiaoxue Feng,1,2 Jia Xu,1,2 Peijun Xu,1,2 Jianlin Huang1,2 1Department of Rheumatology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People’s Republic of China; 2Biomedical Innovation Center, The Sixth ...
Zhang Y, Du K, Feng X, Xu J, Xu P, Huang J   +5 more
doaj  

Serum Reactive Oxygen Metabolites as a Predictor of Clinical Disease Activity Index, Simplified Disease Activity Index, and Boolean Remissions in Rheumatoid Arthritis Patients Treated With Biologic Agents. [PDF]

Cureus, 2021
Nakajima A, Terayama K, Sonobe M, Akatsu Y, Saito J, Norimoto M, Taniguchi S, Kubota A, Aoki Y, Nakagawa K.   +9 more
europepmc   +1 more source

Design and analysis strategies for robust microbiome ageing research

FEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik, İsmail Güderer, Yi Wang, Tayyaba Alvi, Prasoon Pandey, Handan Melike Dönertaş   +5 more
wiley   +1 more source